# Ramelteon in the Prevention of Post-operative Delirium

> **NCT02324153** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 80 (actual)

## Conditions studied

- Delirium
- Delirium, Dementia, Amnestic, Cognitive Disorders
- Delayed Emergence From Anesthesia
- Cognitive Disorders

## Interventions

- **DRUG:** Ramelteon
- **DRUG:** Microcrystalline Cellulose
- **DRUG:** Riboflavin 100 mg

## Key facts

- **NCT ID:** NCT02324153
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-24
- **Primary completion:** 2019-06-26
- **Final completion:** 2019-06-26
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324153, "Ramelteon in the Prevention of Post-operative Delirium". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02324153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*